Published in J Infect Dis on August 31, 2000
Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med (2011) 2.16
Urinary tract infections in adult general practice patients. Br J Gen Pract (2002) 2.10
Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ (2013) 2.07
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med (2005) 1.59
Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J (2011) 1.57
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J Clin Microbiol (2012) 1.53
Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol (2008) 1.49
Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One (2009) 1.49
Dietary factors affecting susceptibility to urinary tract infection. Pediatr Nephrol (2004) 1.46
Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis (2009) 1.14
Urinary tract infections in women: etiology and treatment options. Int J Gen Med (2011) 1.08
The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis (2010) 1.03
Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A (2013) 1.02
Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One (2009) 1.00
Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. Clin Diagn Lab Immunol (2005) 0.96
Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol (2012) 0.96
Role of probiotics in urogenital healthcare. J Midlife Health (2011) 0.92
Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol (2010) 0.92
Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. J Immunol (2014) 0.91
Population structure of gut Escherichia coli and its role in development of extra-intestinal infections. Iran J Microbiol (2010) 0.91
Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.90
Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection. PLoS Pathog (2015) 0.90
Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women. J Gen Intern Med (2008) 0.89
There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.88
Innate immunity and genetic determinants of urinary tract infection susceptibility. Curr Opin Infect Dis (2015) 0.86
Genetic risk for recurrent urinary tract infections in humans: a systematic review. J Biomed Biotechnol (2010) 0.85
The cranberry and the urinary tract. Eur J Clin Microbiol Infect Dis (2007) 0.84
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
Management of recurrent urinary tract infections in healthy adult women. Rev Urol (2013) 0.84
Recurrent urinary tract infections in women. Int Urogynecol J (2014) 0.83
Pelvic Organ Prolapse-Associated Cystitis. Curr Bladder Dysfunct Rep (2014) 0.83
Theodore E. Woodward Award: host-pathogen interactions in community-acquired urinary tract infections. Trans Am Clin Climatol Assoc (2006) 0.79
Recurrent Urinary Tract Infections Management in Women: A review. Sultan Qaboos Univ Med J (2013) 0.79
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
A Murine Model for Escherichia coli Urinary Tract Infection. Methods Mol Biol (2016) 0.77
Adhesive Pili in UTI Pathogenesis and Drug Development. Pathogens (2016) 0.76
Behavioral and Psychosocial Risk Factors Associated with First and Recurrent Cystitis in Indian Women: A Case-control Study. Indian J Community Med (2016) 0.75
Genotypic Characterization of Virulence Factors in Escherichia coli Isolated from Patients with Acute Cystitis, Pyelonephritis and Asymptomatic Bacteriuria. J Clin Diagn Res (2016) 0.75
Impact of genital hygiene and sexual activity on urinary tract infection during pregnancy. Urol Ann (2015) 0.75
Six Out of Ten Women with Recurrent Urinary Tract Infections Complain of Distressful Sexual Dysfunction - A Case-Control Study. Sci Rep (2017) 0.75
The Genetics of Urinary Tract Infections and the Innate Defense of the Kidney and Urinary tract. J Pediatr Genet (2015) 0.75
Genetic Variations in Vesicoureteral Reflux Sequelae. Pathogens (2016) 0.75
Virulence and antimicrobial resistance of common urinary bacteria from asymptomatic students of Niger Delta University, Amassoma, Bayelsa State, Nigeria. J Pharm Bioallied Sci (2016) 0.75
Role of Behavioural Risk Factors in Symptoms Related to UTI Among Nursing Students. J Clin Diagn Res (2015) 0.75
Frequent urinary tract infections in a premenopausal woman. CMAJ (2016) 0.75
One size doesn't fit all: unraveling the diversity of factors and interactions that drive E. coli urovirulence. Ann Transl Med (2017) 0.75
Risk factors for recurrent urinary tract infection in young women. J Urol (2003) 0.75
Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PLoS Pathog (2017) 0.75
Cysticlean® a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study. BMC Urol (2013) 0.75
Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence. Int Urogynecol J (2015) 0.75
Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention. Ci Ji Yi Xue Za Zhi (2017) 0.75
Non-surgical management of recurrent urinary tract infections in women. Transl Androl Urol (2017) 0.75
Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age. Int Urogynecol J (2016) 0.75
High risk of lower urinary tract symptoms in patients with irritable bowel syndrome. Tech Coloproctol (2017) 0.75
Surgical management of recurrent urinary tract infections: a review. Transl Androl Urol (2017) 0.75
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Diagnosis of coliform infection in acutely dysuric women. N Engl J Med (1982) 8.75
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet (1995) 7.46
Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99
The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol (1985) 6.94
Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91
Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis (1985) 6.32
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Management of urinary tract infections in adults. N Engl J Med (1993) 6.01
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis (1999) 5.99
Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol (1983) 5.70
Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am (1997) 5.27
Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1994) 5.15
Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA (1986) 4.93
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA (1999) 4.69
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med (1993) 4.54
Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol (1993) 4.50
Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 4.20
Microtest procedure for isolation of Chlamydia trachomatis. J Clin Microbiol (1981) 4.14
Urinary tract infections in women: diagnosis and treatment. Ann Intern Med (1989) 3.97
Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med (2001) 3.92
Lack of circumcision increases the risk of urinary tract infection in young men. JAMA (1992) 3.90
Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis (2000) 3.86
Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol (1993) 3.82
Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg (1996) 3.76
The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA (1988) 3.73
Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. N Engl J Med (1996) 3.30
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med (1993) 3.18
Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med (1984) 3.15
The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
CDC55, a Saccharomyces cerevisiae gene involved in cellular morphogenesis: identification, characterization, and homology to the B subunit of mammalian type 2A protein phosphatase. Mol Cell Biol (1991) 3.01
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis (1998) 2.98
Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med (1984) 2.89
Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med (2001) 2.83
A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med (2000) 2.81
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA (1995) 2.75
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J Infect Dis (1987) 2.66
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis (2000) 2.64
Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. JAMA (1993) 2.63
Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med (1994) 2.62
Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med (1984) 2.44
Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus. J Infect Dis (1994) 2.43
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol (1990) 2.36
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, Washington. J Clin Microbiol (1987) 2.33
Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med (1987) 2.32
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis (2001) 2.24
Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women. J Clin Microbiol (1990) 2.22
Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med (1981) 2.21
Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol (1985) 2.20
Measurement of pyuria and its relation to bacteriuria. Am J Med (1983) 2.19
Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis (1990) 2.17
The prevalence of hypertension in rural population around Sevagram. J Assoc Physicians India (1993) 2.15
Nucleotide sequence of the variable domains within the major outer membrane protein gene from serovariants of Chlamydia trachomatis. Infect Immun (1993) 2.15
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol (1994) 2.12
Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis. J Clin Microbiol (1991) 2.11
Chlamydial infections. What should we do while waiting for a diagnostic test? West J Med (1981) 2.11
Staining characteristics of six commercially available monoclonal immunofluorescence reagents for direct diagnosis of Chlamydia trachomatis infections. J Clin Microbiol (1988) 2.10
Campylobacter cinaedi is normal intestinal flora in hamsters. J Clin Microbiol (1989) 2.09
Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin Med (1988) 2.07
Bacteremia caused by Campylobacter-like organisms in two male homosexuals. Ann Intern Med (1984) 2.07
Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol (1993) 2.06
Natural history of recurrent urinary tract infections in women. Rev Infect Dis (1991) 2.05
Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother (1989) 2.03
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun (1988) 1.93
Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis (1998) 1.92
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Sexually transmitted diseases in females in a juvenile detention center. Sex Transm Dis (1985) 1.91